Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 13, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2020. Go to the latest filing (Q3 2026)

8.0B USDQ2 2020
Total value of stock positions
8.0B USD
Positions
30
Share of the ten largest
76.3%

The ten largest positions Q2 2020

  1. eBay Inc. 21.1%unchanged
  2. Liberty Global PLC 14.7%▲ +1.6%
  3. Fox Corporation (Class A) 9.2%unchanged
  4. Viasat Inc 6.6%unchanged
  5. Viacomcbs Inc 5.5%▼ −16.3%
  6. Qorvo Inc 4.2%▲ +0.1%
  7. Translate Bio Inc 4.0%▲ +2.8%
  8. HP Inc. 3.9%▼ −10.0%
  9. Alphabet Inc. (Class C) 3.8%▼ −28.6%
  10. McKesson Corporation 3.2%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q2 2020

Positions Q2 2020 per 13F filing, 30 of 30
Symbol Weight Shares Reported value Change Held since
EBAY eBay Inc. 21.1% 32,086,000 1.7B USD unchanged Q4 2018 7 quarters
Liberty Global PLC 14.7% 54,555,407 1.2B USD +1.6% increased Q3 2018 8 quarters
FOXA Fox Corporation (Class A) 9.2% 27,322,720 732.8M USD unchanged Q1 2019 6 quarters
Viasat Inc 6.6% 13,732,068 526.9M USD unchanged Q2 2013 or earlier 29 quarters
Viacomcbs Inc 5.5% 18,837,585 439.3M USD −16.3% reduced Q4 2019 3 quarters
Qorvo Inc 4.2% 3,065,086 338.8M USD +0.1% increased Q1 2017 14 quarters
Translate Bio Inc 4.0% 18,044,239 319.1M USD +2.8% increased Q2 2018 9 quarters
HPQ HP Inc. 3.9% 18,000,681 313.8M USD −10.0% reduced Q4 2019 3 quarters
GOOG Alphabet Inc. (Class C) 3.8% 214,680 303.5M USD −28.6% reduced Q1 2020 2 quarters
MCK McKesson Corporation 3.2% 1,669,181 256.1M USD unchanged Q3 2017 12 quarters
Hd Supply HLDGS Inc 2.9% 6,621,583 229.4M USD +6.5% increased Q1 2020 2 quarters
Akebia Therapeutics Inc 2.6% 15,000,000 203.7M USD −14.4% reduced Q4 2018 7 quarters
Theravance Biopharma Inc 2.4% 9,309,168 195.4M USD unchanged Q2 2014 25 quarters
META Meta Platforms 2.4% 851,500 193.4M USD −57.1% reduced Q1 2020 2 quarters
Nexstar Media Group Inc 2.2% 2,085,000 174.5M USD unchanged Q4 2018 7 quarters
Liberty Global PLC 2.1% 7,657,205 167.4M USD unchanged Q3 2018 8 quarters
FOX Fox Corporation (Class B) 1.9% 5,680,307 152.5M USD unchanged Q1 2019 6 quarters
Atara Biotherapeutics Inc 1.8% 9,922,030 144.6M USD +19.4% increased Q4 2014 23 quarters
HCA HCA Healthcare 1.2% 1,000,000 97.1M USD new Q2 2020 1 quarter
Colony Cap Inc New 0.8% 25,687,370 61.7M USD −48.3% reduced Q2 2018 9 quarters
Veritiv Corp 0.8% 3,564,439 60.5M USD unchanged Q3 2014 24 quarters
COR Cencora 0.6% 468,150 47.2M USD −50.0% reduced Q3 2017 12 quarters
PCG PG&E Corporation 0.5% 4,702,443 41.7M USD −51.5% reduced Q1 2018 10 quarters
Verint Sys Inc 0.3% 616,328 27.8M USD new Q2 2020 1 quarter
Trilogy Metals Inc New 0.3% 12,182,568 24.3M USD unchanged Q3 2016 16 quarters
Univar Solutions Inc 0.3% 1,283,248 21.6M USD −76.7% reduced Q3 2018 8 quarters
VTR Ventas 0.3% 550,000 20.1M USD new Q2 2020 1 quarter
Vista Oil & Gas S A B De C V 0.2% 5,961,709 18.2M USD −3.5% reduced Q3 2019 4 quarters
SS&C Technologies HLDGS Inc < 0.1% 140,516 7.9M USD new Q2 2020 1 quarter
Liberty Media Corp Del < 0.1% 184,867 6.4M USD −85.3% reduced Q1 2020 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 29.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 29.2M USD

Breakdown by sector

  • Consumer Discretionary 21.1%
  • Communication Services 17.3%
  • Health Care 5.0%
  • Technology 3.9%
  • Utilities 0.5%
  • Real Estate 0.3%
  • not in our coverage 51.9%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close